Biostax Corp 
Welcome,         Profile    Billing    Logout  
 2 Products   2 Diseases  2 Products   19 Trials   476 News 
33 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lodonal (naltrexone low dose oral) / Biostax Corp, Statera BioPharma
ACTRN12623000172606: Low Dose Naltrexone in Fibromyalgia - A randomised controlled cross-over trial

Not yet recruiting
4
90
 
Metro South Hospital and Health service, Metro South Hospital and Health service, University of Queensland
fibromyalgia
 
 
ACTRN12622000881730: Low-dose naltrexone as an adjunctive treatment in major depressive disorder.

Recruiting
4
72
 
University of Auckland, Health Research Council of New Zealand
Major depressive disorder (MDD)
 
 
NCT04313972: IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone

Terminated
4
3
US
low-dose naltrexone, Placebo oral tablet
Endeavor Health
Interstitial Cystitis, Painful Bladder Syndrome, Bladder Pain Syndrome, Low Dose Naltrexone, Low-dose Naltrexone, Naltrexone
01/23
02/23
INNOVA, NCT04739995: Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia

Active, not recruiting
4
99
Europe
Low-dose naltrexone, LDN
Fundació Sant Joan de Déu, Carlos III Health Institute
Randomized Controlled Trial
10/24
12/24
NCT05537935: Low Dose Naltrexone for Pain in Patients With HIV

Recruiting
4
60
US
Low Dose Naltrexone, Questionnaires
Emory University
Human Immunodeficiency Virus, Chronic Neuropathic Pain
06/25
06/25
LDN-CRPS, NCT06306157: Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome

Enrolling by invitation
4
40
US
Low dose naltrexone, LDN, Placebo sugar capsules
Hospital for Special Surgery, New York
Complex Regional Pain Syndrome, Chronic Pain, Causalgia, Complex Regional Pain Syndrome Type I, Complex Regional Pain Syndrome Type II
08/26
11/26
NCT05363514: Low Dose Naltrexone Use in Patients With POTS

Not yet recruiting
4
80
NA
Low Dose Naltrexone, LDN, Microcrystalline cellulose, Placebo
University of Calgary
Postural Orthostatic Tachycardia Syndrome
06/28
12/28
2021-002534-16: Placebo-controlled, pharmacological clinical trial to evaluate the effectiveness, cost-utility and neurobiological effects Naltrexone in patients with fibromyalgia Ensayo clínico controlado con placebo para evaluar la efectividad, coste-utilidad y efectos neurobiológicos de la Naltrexona en pacientes con fibromialgia

Not yet recruiting
3
120
Europe
Naltrexone, Film-coated tablet
Fundació Sant Joan de Déu, Instituto de Salud Carlos III (ISCIII)
Fibromyalgia Fibromialgia, Fibromyalgia Fibromialgia, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
NCT05946551: Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial

Terminated
3
5
US
Cetirizine, Famotidine, HRA, Cetirizine Placebo, Famotidine Placebo
Emory University, CURE Drug Repurposing Collaboratory (CDRC)
COVID-19
06/24
06/24
ACTRN12617000274370p: Does naltrexone reduce pain or disability after a whiplash?

Not yet recruiting
2
40
 
Notre Dame University Australia, Joondalup Health Campus
whiplash injury ; whiplash associated disorder
 
 
ACTRN12617000274370: Does naltrexone reduce pain or disability after a whiplash?

Not yet recruiting
2
40
 
Notre Dame University Australia, Joondalup Health Campus
whiplash injury , whiplash associated disorder
 
 
ACTRN12625000131459: Does treatment with naltrexone (a medication) improve quality of life in patients with hypothyroidism (underactive thyroid)?

Not yet recruiting
2
150
 
St. Vincent's Hospital, Sydney, St. Vincent's Clinic Foundation, RACP ESA Research Establishment Fellowship
Hashimoto's disease, Hypothyroidism
 
 
2005-005679-13: An open-label, prospective, multicentric pilot study evaluating safety and symptomatics effects of low dose Naltrexone in patients with primary progressive multiple sclerosis.

Ongoing
2
40
Europe
Capsule, hard
OSPEDALE S. RAFFAELE
multiple sclerosis
 
 
2019-000852-32: A preliminary study of Low Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn’s Disease that failed conventional treatment: The LDN Crohn study.

Not yet recruiting
2
122
Europe
Naltrexone hydrochloride, Tablet
ErasmusMC, ZonMw, ErasmusMC
Inflammatory Bowel Disease, Crohn's disease De ziekte van Crohn, Inflammatory Bowel Disease, Crohn's disease, Diseases [C] - Digestive System Diseases [C06]
 
 
2022-000245-33: To evaluate the effect of low-dose naltrexone (LDN) on pain perception and quality of life in women Ocena wpływu niskich dawek Naltreksonu (LDN) na odczuwanie bólu i jakość życia kobiet z wulwodynią

Not yet recruiting
2
300
Europe
naltrexone, Coated tablet
Medical University of Lublin, Medical Research Agency
Vulvodynia, Chronic pain in the vulva, the area on the outside of a woman's genitals., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
 
 
NCT04450316: Low-dose Naltrexone for Bladder Pain Syndrome

Suspended
2
40
US
Naltrexone, Placebo
Stanford University
Bladder Pain Syndrome, Interstitial Cystitis
07/24
10/24
LoDoNaVasc, NCT03482479: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

Recruiting
2
36
Canada, US
Naltrexone Hydrochloride, Placebo Comparator
University of Pennsylvania
Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis, Polyarteritis Nodosa, Takayasu Arteritis
12/25
12/25
NCT05430152: Low-dose Naltrexone for Post-COVID Fatigue Syndrome

Recruiting
2
160
Canada
Low-Dose Naltrexone, LDN, Placebo
Luis Nacul, University of British Columbia, Canadian Institutes of Health Research (CIHR), Provincial Health Services Authority, Women's Health Research Institute of British Columbia
Post-Viral Fatigue Syndrome
08/25
08/25
NCT04678895: Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy

Recruiting
2
35
US
Naltrexone, LDN, Placebo
Dartmouth-Hitchcock Medical Center
Painful Diabetic Neuropathy
09/25
09/25
LIFT, NCT06366724: Life Improvement Trial

Recruiting
2
160
US
Pyridostigmine, Mestinon, Low-Dose Naltrexone, LDN, Placebo
Brigham and Women's Hospital, Open Medicine Foundation
ME/CFS
09/26
11/26
NCT06723561: Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury

Recruiting
2
10
US
4.5mg daily dose of naltrexone
Medical College of Wisconsin
Central Neuropathic Pain, Spinal Cord Injury
06/26
12/26
NCT05955313 / 2022-000245-33: Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia

Recruiting
2
300
Europe
Naltrexone Hydrochloride, naltrexone
Medical University of Lublin, Medical Research Agency
Vulvodynia, Naltrexone, Quality of Life
12/25
12/26
ACTRN12624001162505: low dose naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and long coronavirus disease (long COVID) symptoms

Not yet recruiting
1
56
 
Griffith University, Griffith University
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Long COVID
 
 
ACTRN12623001042639: Low Dose Naltrexone for the treatment of long COVID-19

Recruiting
1
56
 
Griffith University, Mineral Resources Pty Ltd
long COVID, Post COVID-19 Condition, Post-acute sequelae of COVID-19
 
 
NCT04674670: Psychobiological Mechanisms Underlying Chronic Pain

Completed
N/A
48
Europe
Bromocriptine Mesylate Capsules, Amisulpride 400 MG, Placebo, Placebo for substudy 2
susanne becker, SNSF
Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread
07/23
07/23
NCT05536050: Study of Low-dose Naltrexone in Chronic Migraine With Fibromyalgia

Recruiting
N/A
30
US
Migraine diary and Questionnaires
Thomas Jefferson University
Chronic Migraine, Fibromyalgia, New Daily Persistent Headache
12/23
12/23
NCT05307627: The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging

Withdrawn
N/A
2500
US
low-dose naltrexone, LDN
AgelessRx
Aging
12/23
12/23
LDN-CRPS, NCT02502162: Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome

Recruiting
N/A
120
US
LDN, Placebo
Stanford University
Complex Regional Pain Syndrome
07/27
07/27
naltrexone (JKB-122) / Biostax Corp
NCT02149368: Liver Test Study of Using JKB-122 in HCV-Positive Patients

Recruiting
2
148
RoW
JKB-122, Placebo
Jenken Biosciences Inc., TaiwanJ Pharmaceuticals Co., Ltd
Chronic Hepatitis C
08/16
 
NCT04255069: A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis

Not yet recruiting
2
300
NA
Placebo, Dose 1 JKB-122, JKB-122, Dose 2 JKB-122
TaiwanJ Pharmaceuticals Co., Ltd
Nonalcoholic Steatohepatitis (NASH) With Fibrosis
06/23
12/23
NCT04371718: Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)

Not yet recruiting
2
120
NA
JKB-122, Placebo
TaiwanJ Pharmaceuticals Co., Ltd
Autoimmune Hepatitis
11/23
02/24
NCT04313205: A Pharmacokinetic Study of JKB-122 Tablets Compared to Capsule

Not yet recruiting
1
8
NA
JKB-122 in capsule or tablet form
TaiwanJ Pharmaceuticals Co., Ltd
Autoimmune Hepatitis
12/20
12/20
naltrexone low dose (STAT-205) / Statera BioPharma
NCT04708327: Single-Blind Study of STAT-205 in Mild COVID-19

Recruiting
1
24
US
STAT-205
Cytocom, Inc.
COVID-19
06/22
09/22
STAT-202 / Statera BioPharma, Biostax Corp
No trials found
STAT-203 / Statera BioPharma
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lodonal (naltrexone low dose oral) / Biostax Corp, Statera BioPharma
ACTRN12623000172606: Low Dose Naltrexone in Fibromyalgia - A randomised controlled cross-over trial

Not yet recruiting
4
90
 
Metro South Hospital and Health service, Metro South Hospital and Health service, University of Queensland
fibromyalgia
 
 
ACTRN12622000881730: Low-dose naltrexone as an adjunctive treatment in major depressive disorder.

Recruiting
4
72
 
University of Auckland, Health Research Council of New Zealand
Major depressive disorder (MDD)
 
 
NCT04313972: IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone

Terminated
4
3
US
low-dose naltrexone, Placebo oral tablet
Endeavor Health
Interstitial Cystitis, Painful Bladder Syndrome, Bladder Pain Syndrome, Low Dose Naltrexone, Low-dose Naltrexone, Naltrexone
01/23
02/23
INNOVA, NCT04739995: Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia

Active, not recruiting
4
99
Europe
Low-dose naltrexone, LDN
Fundació Sant Joan de Déu, Carlos III Health Institute
Randomized Controlled Trial
10/24
12/24
NCT05537935: Low Dose Naltrexone for Pain in Patients With HIV

Recruiting
4
60
US
Low Dose Naltrexone, Questionnaires
Emory University
Human Immunodeficiency Virus, Chronic Neuropathic Pain
06/25
06/25
LDN-CRPS, NCT06306157: Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome

Enrolling by invitation
4
40
US
Low dose naltrexone, LDN, Placebo sugar capsules
Hospital for Special Surgery, New York
Complex Regional Pain Syndrome, Chronic Pain, Causalgia, Complex Regional Pain Syndrome Type I, Complex Regional Pain Syndrome Type II
08/26
11/26
NCT05363514: Low Dose Naltrexone Use in Patients With POTS

Not yet recruiting
4
80
NA
Low Dose Naltrexone, LDN, Microcrystalline cellulose, Placebo
University of Calgary
Postural Orthostatic Tachycardia Syndrome
06/28
12/28
2021-002534-16: Placebo-controlled, pharmacological clinical trial to evaluate the effectiveness, cost-utility and neurobiological effects Naltrexone in patients with fibromyalgia Ensayo clínico controlado con placebo para evaluar la efectividad, coste-utilidad y efectos neurobiológicos de la Naltrexona en pacientes con fibromialgia

Not yet recruiting
3
120
Europe
Naltrexone, Film-coated tablet
Fundació Sant Joan de Déu, Instituto de Salud Carlos III (ISCIII)
Fibromyalgia Fibromialgia, Fibromyalgia Fibromialgia, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
NCT05946551: Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial

Terminated
3
5
US
Cetirizine, Famotidine, HRA, Cetirizine Placebo, Famotidine Placebo
Emory University, CURE Drug Repurposing Collaboratory (CDRC)
COVID-19
06/24
06/24
ACTRN12617000274370p: Does naltrexone reduce pain or disability after a whiplash?

Not yet recruiting
2
40
 
Notre Dame University Australia, Joondalup Health Campus
whiplash injury ; whiplash associated disorder
 
 
ACTRN12617000274370: Does naltrexone reduce pain or disability after a whiplash?

Not yet recruiting
2
40
 
Notre Dame University Australia, Joondalup Health Campus
whiplash injury , whiplash associated disorder
 
 
ACTRN12625000131459: Does treatment with naltrexone (a medication) improve quality of life in patients with hypothyroidism (underactive thyroid)?

Not yet recruiting
2
150
 
St. Vincent's Hospital, Sydney, St. Vincent's Clinic Foundation, RACP ESA Research Establishment Fellowship
Hashimoto's disease, Hypothyroidism
 
 
2005-005679-13: An open-label, prospective, multicentric pilot study evaluating safety and symptomatics effects of low dose Naltrexone in patients with primary progressive multiple sclerosis.

Ongoing
2
40
Europe
Capsule, hard
OSPEDALE S. RAFFAELE
multiple sclerosis
 
 
2019-000852-32: A preliminary study of Low Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn’s Disease that failed conventional treatment: The LDN Crohn study.

Not yet recruiting
2
122
Europe
Naltrexone hydrochloride, Tablet
ErasmusMC, ZonMw, ErasmusMC
Inflammatory Bowel Disease, Crohn's disease De ziekte van Crohn, Inflammatory Bowel Disease, Crohn's disease, Diseases [C] - Digestive System Diseases [C06]
 
 
2022-000245-33: To evaluate the effect of low-dose naltrexone (LDN) on pain perception and quality of life in women Ocena wpływu niskich dawek Naltreksonu (LDN) na odczuwanie bólu i jakość życia kobiet z wulwodynią

Not yet recruiting
2
300
Europe
naltrexone, Coated tablet
Medical University of Lublin, Medical Research Agency
Vulvodynia, Chronic pain in the vulva, the area on the outside of a woman's genitals., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
 
 
NCT04450316: Low-dose Naltrexone for Bladder Pain Syndrome

Suspended
2
40
US
Naltrexone, Placebo
Stanford University
Bladder Pain Syndrome, Interstitial Cystitis
07/24
10/24
LoDoNaVasc, NCT03482479: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

Recruiting
2
36
Canada, US
Naltrexone Hydrochloride, Placebo Comparator
University of Pennsylvania
Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis, Polyarteritis Nodosa, Takayasu Arteritis
12/25
12/25
NCT05430152: Low-dose Naltrexone for Post-COVID Fatigue Syndrome

Recruiting
2
160
Canada
Low-Dose Naltrexone, LDN, Placebo
Luis Nacul, University of British Columbia, Canadian Institutes of Health Research (CIHR), Provincial Health Services Authority, Women's Health Research Institute of British Columbia
Post-Viral Fatigue Syndrome
08/25
08/25
NCT04678895: Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy

Recruiting
2
35
US
Naltrexone, LDN, Placebo
Dartmouth-Hitchcock Medical Center
Painful Diabetic Neuropathy
09/25
09/25
LIFT, NCT06366724: Life Improvement Trial

Recruiting
2
160
US
Pyridostigmine, Mestinon, Low-Dose Naltrexone, LDN, Placebo
Brigham and Women's Hospital, Open Medicine Foundation
ME/CFS
09/26
11/26
NCT06723561: Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury

Recruiting
2
10
US
4.5mg daily dose of naltrexone
Medical College of Wisconsin
Central Neuropathic Pain, Spinal Cord Injury
06/26
12/26
NCT05955313 / 2022-000245-33: Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia

Recruiting
2
300
Europe
Naltrexone Hydrochloride, naltrexone
Medical University of Lublin, Medical Research Agency
Vulvodynia, Naltrexone, Quality of Life
12/25
12/26
ACTRN12624001162505: low dose naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and long coronavirus disease (long COVID) symptoms

Not yet recruiting
1
56
 
Griffith University, Griffith University
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Long COVID
 
 
ACTRN12623001042639: Low Dose Naltrexone for the treatment of long COVID-19

Recruiting
1
56
 
Griffith University, Mineral Resources Pty Ltd
long COVID, Post COVID-19 Condition, Post-acute sequelae of COVID-19
 
 
NCT04674670: Psychobiological Mechanisms Underlying Chronic Pain

Completed
N/A
48
Europe
Bromocriptine Mesylate Capsules, Amisulpride 400 MG, Placebo, Placebo for substudy 2
susanne becker, SNSF
Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread
07/23
07/23
NCT05536050: Study of Low-dose Naltrexone in Chronic Migraine With Fibromyalgia

Recruiting
N/A
30
US
Migraine diary and Questionnaires
Thomas Jefferson University
Chronic Migraine, Fibromyalgia, New Daily Persistent Headache
12/23
12/23
NCT05307627: The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging

Withdrawn
N/A
2500
US
low-dose naltrexone, LDN
AgelessRx
Aging
12/23
12/23
LDN-CRPS, NCT02502162: Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome

Recruiting
N/A
120
US
LDN, Placebo
Stanford University
Complex Regional Pain Syndrome
07/27
07/27
naltrexone (JKB-122) / Biostax Corp
NCT02149368: Liver Test Study of Using JKB-122 in HCV-Positive Patients

Recruiting
2
148
RoW
JKB-122, Placebo
Jenken Biosciences Inc., TaiwanJ Pharmaceuticals Co., Ltd
Chronic Hepatitis C
08/16
 
NCT04255069: A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis

Not yet recruiting
2
300
NA
Placebo, Dose 1 JKB-122, JKB-122, Dose 2 JKB-122
TaiwanJ Pharmaceuticals Co., Ltd
Nonalcoholic Steatohepatitis (NASH) With Fibrosis
06/23
12/23
NCT04371718: Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)

Not yet recruiting
2
120
NA
JKB-122, Placebo
TaiwanJ Pharmaceuticals Co., Ltd
Autoimmune Hepatitis
11/23
02/24
NCT04313205: A Pharmacokinetic Study of JKB-122 Tablets Compared to Capsule

Not yet recruiting
1
8
NA
JKB-122 in capsule or tablet form
TaiwanJ Pharmaceuticals Co., Ltd
Autoimmune Hepatitis
12/20
12/20
naltrexone low dose (STAT-205) / Statera BioPharma
NCT04708327: Single-Blind Study of STAT-205 in Mild COVID-19

Recruiting
1
24
US
STAT-205
Cytocom, Inc.
COVID-19
06/22
09/22
STAT-202 / Statera BioPharma, Biostax Corp
No trials found
STAT-203 / Statera BioPharma
No trials found

Download Options